BioCentury
ARTICLE | Company News

Aphios, Boston University Medical Center, NIH cancer news

September 24, 2007 7:00 AM UTC

Aphios and the center received a one-year $260,000 Phase I Small Business Technology Transfer (STTR) grant from NIH's National Cancer Institute to develop APH-M109 to treat hormone-refractory prostat...